IRD – opus genetics, inc. (US:NASDAQ)
Stock Stats
News
Opus Genetics, Inc. (NASDAQ: IRD) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $8.00 price target on the stock.
Opus Genetics Announces Financial Results for Third Quarter 2024 and Provides Corporate Update
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.